日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled Trial

数字疗法（CT-155/BI 3972080）治疗精神分裂症患者阴性症状的有效性、参与度和安全性：3期CONVOKE随机对照试验方案

期刊:JMIR Research Protocols
影响因子:1.5
doi:10.2196/81293
Lakhan, Shaheen E; Dorner-Ciossek, Cornelia; Besedina, Olya; Dickerson, Faith; Hastedt, Claudia; Isla, Ridwana; Kahn, René S; Lindenmayer, Jean-Pierre; Mehta, Ruchi; Snipes, Cassandra; Speier, Austin; Tang, Wenbo; Willis, Bailey; Fernandez, Jamie Winderbaum; von der Goltz, Christoph; Pratap, Abhishek
CT-1
精神分裂症
神经科学
发表日期：2025
文献求助 收藏

Balancing sufficiency and impact in reporting standards for mass spectrometry imaging experiments

平衡质谱成像实验报告标准的充分性和影响

期刊:Gigascience
影响因子:3.9
doi:10.1093/gigascience/giy102
Gustafsson, Ove J R; Winderbaum, Lyron J; Condina, Mark R; Boughton, Berin A; Hamilton, Brett R; Undheim, Eivind A B; Becker, Michael; Hoffmann, Peter
发表日期：2018
文献求助 收藏

Raw N-glycan mass spectrometry imaging data on formalin-fixed mouse kidney

福尔马林固定小鼠肾脏的原始N-糖质谱成像数据

期刊:Data in Brief
影响因子:1.4
doi:10.1016/j.dib.2018.08.186
Gustafsson, Ove J R; Briggs, Matthew T; Condina, Mark R; Winderbaum, Lyron J; Pelzing, Matthias; McColl, Shaun R; Everest-Dass, Arun V; Packer, Nicolle H; Hoffmann, Peter
发表日期：2018
文献求助 收藏

EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP

EGCG通过雌激素受体介导的ADAM10激活，促进APP的非淀粉样蛋白生成加工过程。

期刊:FEBS Letters
影响因子:3
doi:10.1016/j.febslet.2010.09.022
Fernandez, Jamie Winderbaum; Rezai-Zadeh, Kavon; Obregon, Demian; Tan, Jun
信号转导
APP
ADAM10
免疫/内分泌
ADA
发表日期：2010
文献求助 收藏